DE69736230D1 - Behandlung einer hämoglobinstörung - Google Patents

Behandlung einer hämoglobinstörung

Info

Publication number
DE69736230D1
DE69736230D1 DE69736230T DE69736230T DE69736230D1 DE 69736230 D1 DE69736230 D1 DE 69736230D1 DE 69736230 T DE69736230 T DE 69736230T DE 69736230 T DE69736230 T DE 69736230T DE 69736230 D1 DE69736230 D1 DE 69736230D1
Authority
DE
Germany
Prior art keywords
treatment
hemoglobin disorder
hemoglobin
disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69736230T
Other languages
English (en)
Other versions
DE69736230T2 (de
Inventor
Alvin Head
M Zapol
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of DE69736230D1 publication Critical patent/DE69736230D1/de
Application granted granted Critical
Publication of DE69736230T2 publication Critical patent/DE69736230T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69736230T 1996-04-05 1997-04-03 Behandlung einer hämoglobinstörung Expired - Lifetime DE69736230T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1488696P 1996-04-05 1996-04-05
US14886 1996-04-05
PCT/US1997/005633 WO1997037644A1 (en) 1996-04-05 1997-04-03 Treatment of a hemoglobinopathy

Publications (2)

Publication Number Publication Date
DE69736230D1 true DE69736230D1 (de) 2006-08-10
DE69736230T2 DE69736230T2 (de) 2007-05-31

Family

ID=21768361

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69736230T Expired - Lifetime DE69736230T2 (de) 1996-04-05 1997-04-03 Behandlung einer hämoglobinstörung

Country Status (15)

Country Link
US (1) US5885621A (de)
EP (1) EP0914103B1 (de)
JP (1) JP2000510448A (de)
CN (1) CN1208053C (de)
AP (1) AP897A (de)
AT (1) ATE331505T1 (de)
AU (1) AU720686B2 (de)
BR (1) BR9708601A (de)
CA (1) CA2251530C (de)
DE (1) DE69736230T2 (de)
DK (1) DK0914103T3 (de)
ES (1) ES2267141T3 (de)
OA (1) OA10893A (de)
PT (1) PT914103E (de)
WO (1) WO1997037644A1 (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063407A (en) * 1995-02-16 2000-05-16 The General Hospital Corporation Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
US6911427B1 (en) 1995-09-15 2005-06-28 Duke University No-modified hemoglobins and uses therefore
US6197745B1 (en) 1995-09-15 2001-03-06 Duke University Methods for producing nitrosated hemoglobins and therapeutic uses therefor
US6627738B2 (en) 1995-09-15 2003-09-30 Duke University No-modified hemoglobins and uses therefor
US8128963B2 (en) * 1996-09-27 2012-03-06 The Trustees Of Columbia University In The City Of New York Methods for treating ischemic disorders using carbon monoxide
US6656452B1 (en) 1997-10-21 2003-12-02 The General Hospital Corporation Use of inhaled NO as anti-inflammatory agent
CA2254645A1 (en) * 1998-11-23 2000-05-23 Pulmonox Medical Corporation Method and apparatus for treatment of respiratory infections by nitric oxide inhalation
US20070086954A1 (en) * 1998-11-23 2007-04-19 Miller Christopher C Method and apparatus for treatment of respiratory infections by nitric oxide inhalation
US7678390B2 (en) 1999-04-01 2010-03-16 Yale University Carbon monoxide as a biomarker and therapeutic agent
FR2794647A1 (fr) * 1999-06-11 2000-12-15 Centre Nat Rech Scient Compositions pharmaceutique comprenant du no ou au moins un compose capable de liberer ou d'induire la formation de no dans les cellules
US7516742B2 (en) * 1999-11-24 2009-04-14 Cardinal Health 207, Inc. Method and apparatus for delivery of inhaled nitric oxide to spontaneous-breathing and mechanically-ventilated patients with intermittent dosing
US6601580B1 (en) 2000-06-28 2003-08-05 The General Hospital Corporation Enhancing therapeutic effectiveness of nitric oxide inhalation
FR2812197B1 (fr) * 2000-07-27 2003-01-03 Air Liquide Sante Int Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches
FR2816212A1 (fr) * 2000-11-03 2002-05-10 Air Liquide Sante Int Utilisation de monoxyde de carbone (co) dans le traitement des inflammations du systeme cardiovasculaire
US7335181B2 (en) * 2000-12-26 2008-02-26 Pulmonox Technologies Corporation Nitric oxide decontamination of the upper respiratory tract
US6432077B1 (en) * 2000-12-26 2002-08-13 Sensormedics Corporation Device and method for treatment of surface infections with nitric oxide
US7122018B2 (en) * 2000-12-26 2006-10-17 Sensormedics Corporation Device and method for treatment of wounds with nitric oxide
GB0111872D0 (en) * 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
SI1404811T1 (sl) * 2001-06-21 2009-04-30 Beth Israel Hospital Ogljikov monoksid izboljša rezultate pri presaditvi tkiva in organov ter prepreči apoptozo
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
WO2003066067A2 (en) * 2002-02-04 2003-08-14 Alfama - Investigaçao E Desenvolvimento De Produtos Farmaceuticos Lda. Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
US20080026984A1 (en) * 2002-02-04 2008-01-31 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
US7968605B2 (en) * 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
JP2005525848A (ja) * 2002-02-13 2005-09-02 ベス イスラエル ディコネス メディカル センター 血管疾患の治療方法
WO2003088981A1 (en) * 2002-04-15 2003-10-30 University Of Pittsburgh Of The Commonwealth System Of Higher Education Methods of treating necrotizing enterocolitis
CA2482260A1 (en) 2002-04-15 2003-10-30 Beth Israel Deaconess Medical Center Inc. Use of heme oxygenase-1 and products of heme degradation
WO2003088923A2 (en) * 2002-04-15 2003-10-30 University Of Pittsburgh Of The Commonwealth System Of Higher Education Methods of treating ileus
UA83465C2 (uk) 2002-05-17 2008-07-25 Йельский Университет Спосіб лікування гепатитів монооксидом вуглецю
PL374375A1 (en) * 2002-06-05 2005-10-17 Yale University Methods of treating angiogenesis, tumor growth, and metastasis
WO2004000368A1 (en) * 2002-06-21 2003-12-31 University Of Pittsburgh Of The Commonwealth System Of Higher Education Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
US7531133B2 (en) * 2002-09-10 2009-05-12 Pulmonox Technologies Corporation Use of nitric oxide gas in an extracorporeal circuitry to treat blood plasma
EA200500782A1 (ru) * 2002-11-07 2005-10-27 Юниверсити Оф Питтсбург Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн Лечение геморрагического шока
GB2395432B (en) * 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
US20070207217A1 (en) * 2003-02-03 2007-09-06 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Method for treating a mammal by administration of a compound having the ability to release CO
WO2005007173A1 (en) * 2003-07-09 2005-01-27 The Government Of The United States Of America As Represented By The Secretary, Department Of Health Use of nitrite salts for the treatment of cardiovascular conditions
US20050255178A1 (en) * 2004-02-04 2005-11-17 Bloch Kenneth D Enhancing the effectiveness of an inhaled therapeutic gas
US8518457B2 (en) * 2004-05-11 2013-08-27 Pulmonox Technologies Corporation Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant
MXPA06013111A (es) 2004-05-11 2007-05-23 Sensormedics Corp Dosificacion intermitente de gas de oxido nitrico.
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
US20070154570A1 (en) * 2004-09-29 2007-07-05 Miller Christopher C Use of nitric oxide in the treatment and disinfection of biofilms
US8557300B2 (en) * 2005-05-19 2013-10-15 University Of Cincinnati Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
US7523752B2 (en) * 2005-09-21 2009-04-28 Ino Therapeutics, Llc System and method of administering a pharmaceutical gas to a patient
US8893717B2 (en) 2005-09-21 2014-11-25 Ino Therapeutics Llc Systems and methods of administering a pharmaceutical gas to a patient
US20070116785A1 (en) * 2005-11-18 2007-05-24 Miller Christopher C Nitric oxide as an anti-viral agent, vaccine and vaccine adjuvant
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
US8079998B2 (en) * 2006-10-20 2011-12-20 Pulmonox Technologies Corporation Methods and devices for the delivery of therapeutic gases including nitric oxide
KR20090087900A (ko) * 2006-11-07 2009-08-18 더 제너럴 하스피탈 코포레이션 혈관작용성 산소운반체에 의해 유도되는 혈관수축의 감소
US20080193566A1 (en) * 2007-02-09 2008-08-14 Miller Christopher C Use of high dose concentrations of gaseous nitric oxide
EP2237788A4 (de) * 2007-12-27 2013-06-05 Aires Pharmaceuticals Inc Aerosolisierte nitrit- und stickoxidspendende verbindungen und ihre verwendung
CA2763111C (en) 2009-05-27 2019-09-24 Ino Therapeutics Llc Devices and methods for engaging indexed valve and pressurized canister assembly with collar and for linear actuation by plunger assembly into fluid communication with device for regulating drug delivery
AU2009202685B1 (en) 2009-06-30 2010-08-19 Ino Therapeutics Llc Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension
US20120201906A1 (en) * 2009-09-08 2012-08-09 Reynolds James D Novel medical uses for no and no donor compounds
ES2656237T3 (es) 2011-04-19 2018-02-26 Alfama, Inc. Moléculas liberadoras de monóxido de carbono y usos de las mismas
ES2628634T3 (es) 2011-07-21 2017-08-03 Alfama, Inc. Moléculas liberadoras de monóxido de carbono-rutenio y usos de las mismas
EP2763935B2 (de) 2011-10-03 2023-06-07 NitricGen, Inc. Vorrichtung und verfahren zur erzeugung von stickoxid in kontrollierten und genauen mengen
WO2013070592A1 (en) 2011-11-07 2013-05-16 The General Hospital Corporation Treatment of red blood cells
CA2867022C (en) 2012-03-15 2020-12-15 Ino Therapeutics Llc Methods of administering high concentrations of nitric oxide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954526A (en) * 1989-02-28 1990-09-04 The United States Of America As Represented By The Department Of Health And Human Services Stabilized nitric oxide - primary amine complexes useful as cardiovascular agents
US5380945A (en) * 1989-06-21 1995-01-10 Abbott Laboratories Guanidino compounds as regulators of nitric oxide synthase
US5155137A (en) * 1990-09-20 1992-10-13 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Complexes of nitric oxide with polyamines
DE560928T1 (de) * 1990-12-05 1994-09-22 Gen Hospital Corp Vorrichtung zum behandeln einer lungengefässverengung und von asthma.
CA2175467A1 (en) * 1993-11-02 1995-05-11 David A. Wink, Jr. Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury

Also Published As

Publication number Publication date
DK0914103T3 (da) 2006-10-23
CA2251530A1 (en) 1997-10-16
CN1227485A (zh) 1999-09-01
ATE331505T1 (de) 2006-07-15
ES2267141T3 (es) 2007-03-01
AP9801358A0 (en) 1998-12-31
PT914103E (pt) 2006-09-29
BR9708601A (pt) 1999-08-03
WO1997037644A1 (en) 1997-10-16
EP0914103B1 (de) 2006-06-28
JP2000510448A (ja) 2000-08-15
US5885621A (en) 1999-03-23
DE69736230T2 (de) 2007-05-31
EP0914103A4 (de) 2003-09-03
AP897A (en) 2000-11-17
CN1208053C (zh) 2005-06-29
AU720686B2 (en) 2000-06-08
AU2440397A (en) 1997-10-29
EP0914103A1 (de) 1999-05-12
CA2251530C (en) 2002-11-19
OA10893A (en) 2001-10-11

Similar Documents

Publication Publication Date Title
DE69736230D1 (de) Behandlung einer hämoglobinstörung
DK0664957T4 (da) Behandling af fjerkræ
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
DE59500555D1 (de) Mittel zur Wasserbehandlung
NO983266D0 (no) Distribuert Behandling
NO984431L (no) FremgangsmÕte for behandling av smerte
DE69926385D1 (de) Behandlung von geweben
DE69524138D1 (de) Hautbehandlungsmittel
ATA76995A (de) Stabiles präparat zur behandlung von blutgerinnungsstörungen
DE69729817D1 (de) Behandlung von Aldehyd-fixierten Geweben
DE59707519D1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen
NO983263D0 (no) Distribuert behandling
NO984446D0 (no) FremgangsmÕte for behandling av smerte
ATE226071T1 (de) Antikonvulsive derivate zur behandlung von neuropathischem schmerz
IS4789A (is) Meðferðarefnasambönd
ID21874A (id) Penggunaan 1-hidroksi-2-piridon untuk pengobatan infeksi urap kulit
DE69525349D1 (de) Behandlung von sclaganfall mit einer infiltration von makrophagen assoziiert
DE69518438T2 (de) Behandlung von übereregten nervenzellenfunktionen
DE69717846T2 (de) Behandlungsverfahren von laktamen
NO984189D0 (no) Fremgangsmåte for behandling av bipolar forstyrrelse
ATA137796A (de) Faserbehandlungsmittel
ATE204167T1 (de) Antikonvulsive derivate zur behandlung von psoriasis
DE29612101U1 (de) Behandlungsliege
DE29723443U1 (de) Behandlungsliege
DE9418331U1 (de) Behandlungsliege

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: DF-MP, 80333 MUENCHEN